Abstract
AbstractThe detection and tracking of progressive memory impairments, particularly in the context of neurodegenerative disorders, relies predominantly on traditional neuropsychological assessment and short cognitive screening tools. These methods, however, are resource-intensive and lack the accessibility and/or the repeatability necessary for effective early identification and tracking interventions. This study addresses the critical need for reliable and efficient diagnostic tools to track and predict memory decline in clinical settings. We demonstrate that an online, remote model-based memory assessment, can identify individuals with Mild Cognitive Impairment (MCI) with an accuracy rate exceeding 84% in a single 8-minute session. Furthermore, the test can be repeated multiple times with increasing accuracy over multiple assessments. The system’s ability to monitor individual memory function inexpensively and longitudinally across various materials offers a robust and repeatable alternative to the static measures currently employed. Our findings show that traditional methods to assess memory decline could be replaced by adaptive, precise, and patient-friendly online tools based on computational modeling techniques. Moreover, our findings also open avenues for the proactive management of Alzheimer’s disease and other dementias, as well as sensitively tracking the effect of interventions in early disease.Significance StatementWe introduce, for the first time, a dependable, reliable, and repeatable model-based system for the online assessment of clinical memory impairment. Our findings demonstrate that this system can efficiently detect memory impairments using only 8 minutes of data collected online, marking a significant improvement over traditional assessments that typically require 3 hours in a clinical setting. These findings open up the possibility of inexpensive population-level monitoring of memory function.
Publisher
Cold Spring Harbor Laboratory
Reference31 articles.
1. Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population;J Prev Alzheimers Dis,2024
2. Observational study of patient characteristics associated with a timely diagnosis of dementia and mild cognitive impairment without dementia;J. Gen. Intern. Med,2022
3. Who has undiagnosed dementia? A cross-sectional analysis of participants of the Aging, Demographics and Memory Study
4. Sex, Race, and Age Differences in Prevalence of Dementia in Medicare Claims and Survey Data;J. Gerontol. B Psychol. Sci. Soc. Sci,2021
5. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER);a randomised controlled trial. Lancet,2015